Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, signaling a new version of the page. This update is administrative and does not alter the study content presented.
    Difference
    0.1%
    Check dated 2026-08-11T15:48:44.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    A new Nat Commun publication citation was added to the Publications section, including the full citation and DOI. The update also removes the 'Online ahead of print' note from the previous reference and adds a 'Revision: v3.6.4' tag.
    Difference
    0.1%
    Check dated 2026-07-28T05:26:19.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page's revision history indicates a new revision tag (v3.6.3) was added with dates 2026-07-02 and 2026-06-30, and the previous revision v3.6.2 was removed (dates 2026-04-02 and 2026-03-31). These entries reflect backend/versioning updates rather than changes to visible content.
    Difference
    0.3%
    Check dated 2026-07-06T18:15:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.2 on the page, indicating a post-release adjustment to the page template or documentation. This represents a small internal update rather than any change to the study information presented.
    Difference
    0.1%
    Check dated 2026-06-29T14:47:15.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page now states recruitment is closed with a new 'No longer looking for participants' notice and adds navigation/help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'). It also updates the Intervention/Treatment label formatting and includes a site revision note 'Revision: v3.6.0' (replacing 'Revision: v3.5.5').
    Difference
    0.4%
    Check dated 2026-06-15T08:24:43.000Z thumbnail image
  9. Check
    83 days ago
    Change Detected
    Summary
    Footer branding and links were updated to reflect the sponsor and related trial site, and the page revision tag was updated from v3.5.4 to v3.5.5.
    Difference
    0.2%
    Check dated 2026-06-08T03:50:29.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.